| 000 | 01322 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513141034.0 | ||
| 264 | 0 | _c19980416 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0270-9139 | ||
| 024 | 7 |
_a10.1002/hep.510270422 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmit, J W | |
| 245 | 0 | 0 |
_aContribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cApr 1998 |
||
| 300 |
_a1056-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBile _xmetabolism |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xmetabolism |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aVecuronium Bromide _xpharmacokinetics |
| 700 | 1 | _aSchinkel, A H | |
| 700 | 1 | _aMüller, M | |
| 700 | 1 | _aWeert, B | |
| 700 | 1 | _aMeijer, D K | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 27 _gno. 4 _gp. 1056-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.510270422 _zAvailable from publisher's website |
| 999 |
_c9505017 _d9505017 |
||